Ramat Gan, Israel

Genady Kostenich

This inventor holds 10 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Tel Hashomer Medical Research Infrastructure and Services Ltd., Tel Aviv University. Active years: 2014-2026.

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Bat Yam, IL (2014)
  • Ramat Gan, IL (2019 - 2023)
  • Tel Aviv, IL (2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Genady Kostenich

Introduction: Genady Kostenich, a visionary inventor hailing from Ramat-Gan, Israel, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Genady Kostenich's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software algorithm for optimizing energy consumption in smart homes.

Career Highlights: With a career spanning over two decades, Genady Kostenich has established himself as a pioneer in the tech industry. He has held key positions in leading research institutions and has been instrumental in developing innovative solutions for complex technological challenges.

Collaborations: Throughout his career, Genady Kostenich has collaborated with top engineers, scientists, and designers from around the world. His ability to work seamlessly in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: In conclusion, Genady Kostenich's relentless pursuit of innovation and his passion for pushing the boundaries of technology have cemented his reputation as a trailblazer in the field of inventions. His work continues to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…